Paul McBarron
2011
In 2011, Paul McBarron earned a total compensation of $415.3K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, and Secretary at Cyclacel Pharmaceuticals, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $38,633 |
|---|---|
| Salary | $298,175 |
| Stock Awards | $62,250 |
| Other | $16,209 |
| Total | $415,267 |
McBarron received $298.2K in salary, accounting for 72% of the total pay in 2011.
McBarron also received $38.6K in bonus, $62.3K in stock awards and $16.2K in other compensation.
Rankings
In 2011, Paul McBarron's compensation ranked 8,568th out of 10,747 executives tracked by ExecPay. In other words, McBarron earned more than 20.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,568 out of 10,747 | 20th |
Division Manufacturing | 3,178 out of 3,960 | 20th |
Major group Chemicals And Allied Products | 791 out of 1,033 | 23rd |
Industry group Drugs | 578 out of 781 | 26th |
Industry Pharmaceutical Preparations | 447 out of 571 | 22nd |
Source: SEC filing on April 3, 2013.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2011.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020